Abstract
BackgroundMEDI-546 is an investigational human IgG1κ monoclonal antibody directed against subunit 1 of the type I interferon receptor (IFNAR1). An open-label single- and multiple-dose phase 1a clinical trial has been...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have